MedTrace Logo

Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period

NCT00501254 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-07-18

No results posted yet for this study

Summary

Evaluation of the pharmacodynamic profile (antiaggregant profile, balance of prostanoids and nitric oxid) of a ASA-SR (slow-release)formulation in comparison with a ASA NR (normal release), 150 mg, during 12 months of treatment.

Conditions

Interventions

DRUG

Slow release acetyl salicylic acid

BEHAVIORAL

Antithrombotic effect

Sponsors & Collaborators

  • Rottapharm Spain

    lead INDUSTRY

Principal Investigators

  • Eloy Rueda, MD · Hosp. Universitario Virgen de la Victoria, Málaga (Spain)

  • José Pedro de la Cruz, MD, phD · Departamento de Farmacología y Terapéutica Clínica Facultad de Medicina, Universidad de Málaga

  • José Antonio González Correa, MD, phD · Departamento de Farmacología y Terapéutica Clínica Facultad de Medicina, Universidad de Málaga

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Completion
2007-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00501254 on ClinicalTrials.gov